from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2250c/-

LFCtreatmentdescriptionclass of inhibitor

0.051

Amikacinug/mL Amikacintranslation

-0.358

Cap5-10ug/mL Capreomycintranslation

1.407

Rox10-50 ug/mL Roxithromycintranslation

0.368

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.553

Rif0.2-5ug/mL Rifampicintranscription

0.161

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.129

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.173

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.614

CPZ10-50 ug/mL Chlorpromazinerespiration

0.037

Clofazimine10-13 ug/mL Clofaziminerespiration

0.536

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.855

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.605

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.097

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.041

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.264

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.394

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.928

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.760

Nigericin50 uM Nigericinrespiration

0.070

TRC10-150 ug/mL Triclosanrespiration

0.856

TRZ10-25 ug/mL Thioridazinerespiration

0.961

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.341

menadione6-10 ug/mL Menadionerespiration

-0.199

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.243

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.437

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.163

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.314

NRP_1Non-replicating persistence stage 1dosRassociated

0.377

Amp0.2mg/mL AmpicillincellWall

-0.286

Cephalexin20-100 ug/mL CephalexincellWall

0.512

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.151

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.076

EMB10-20 ug/mL EthambutolcellWall

0.565

Eta12-40 ug/mL EthionamidecellWall

-0.736

INH0.2-0.4 ug/mL IsoniazidcellWall

0.497

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.251

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.667

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.987

BZA0.12 mg/mL BenzamidearomaticAmides

-0.136

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.066

H2O24 mM hydrogen peroxideDNAdamaging

-0.269

Levo10 ug/mL LevofloxacinDNAdamaging

0.488

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.262

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.350

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.025

UVUV-irradiationDNAdamaging

-0.411

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.405

Antimycin12.5-50 ug/mL Antimycin A?

-0.454

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.260

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.755

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.190

PA8240.2-2 ug/mL PA-824?

-0.117

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.313

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.592

Verapamil50 uM Verapamil?

-1.384

mercaptoethanol2 mM 2-Mercaptoethanol?

0.066

methoxatin10-20 ug/mL Methoxatin?